A nurse is preparing to administer medications to a client who has type 1 diabetes mellitus. The client takes lispro Insulin and has a new prescription for pramlintide. Which of the following actions should the nurse take?

A. "Monitor the client for weight gain.": Pramlintide, an amylin analog, is not commonly associated with weight gain. In fact, it may assist with weight loss by promoting satiety. Monitoring for weight gain is not the primary action associated with this medication. B. "Monitor for hypoglycemia for 3 hr after pramlintide administration.": Pramlintide, when used with insulin, can increase the risk of hypoglycemia, especially after meals. The nurse should monitor for hypoglycemia for up to 3 hours after administration because of its effects on insulin and delayed gastric emptying. C. "Inject the pramlintide in the client's upper arm.": Pramlintide is typically injected subcutaneously in the abdomen or thigh, not the upper arm. The nurse should administer it in a recommended site to ensure proper absorption. D. "Administer pramlintide 30 min prior to a meal.": Pramlintide should be administered immediately before a meal, not 30 minutes prior. It is most effective when taken just before eating to control postprandial blood sugar levels.